Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.

Horatio Washington Depot Technologies LLC v. Tolmar, Inc.

United States District Court, D. Delaware

March 20, 2019

HORATIO WASHINGTON DEPOT TECHNOLOGIES LLC, Plaintiff,
v.
TOLMAR, INC., TOLMAR PHARMACEUTICALS, INC., and TOLMAR THERAPEUTICS, INC., Defendants.

          MEMORANDUM ORDER

          HONORABLE LEONARD P. STARK UNITED STATES DISTRICT COURT

         WHEREAS, Magistrate Judge Burke issued a 30-page Report and Recommendation[1]("Report") (D.I. 77), dated November 1, 2018, recommending that the Court grant-in-part and deny-in-part[2] Defendants Tolmar, Inc., Tolmar Pharmaceuticals, Inc., and Tolmar Therapeutics, Inc.'s (together, "Tolmar") motion (D.I. 12) to dismiss Plaintiff Horatio Washington Depot Technologies LLC's ("Horatio") Complaint (D.I. 1);

         WHEREAS, on November 15, 2018, Horatio objected ("Horatio's Objections" or "Horatio's Objs.") (D.I. 89) to the Report, specifically objecting to the Report's conclusion that the patent marking statute, 35 U.S.C. § 287, bars Horatio from recovering damages for infringement of the '547 and '261 patents;

         WHEREAS, also on November 15, 2018, Tolmar objected ("Tolmar's Objections" or "Tolmar's Objs.") (D.I. 88) to the Report, specifically objecting to the Report's denial of Tolmar's motion pertaining to claim 23 of the '261 patent and claim 16 of the '712 patent;

         WHEREAS, on November 29, 2018, Tolmar responded ("Tolmar Resp.") (D.I. 96) to Horatio's Objections, and Horatio responded ("Horatio Resp.") (D.I. 97) to Tolmar's Objections;

         WHEREAS, the Court has considered the parties' objections and responses de novo, see St. Clair Intellectual Prop. Consultants, Inc. v. Matsushita Elec. Indus. Co., Ltd., 691 F.Supp.2d 538, 541-42 (D. Del. 2010); 28 U.S.C. § 636(b)(1); Fed.R.Civ.P. 72(b)(3);

         NOW THEREFORE, IT IS HEREBY ORDERED that Horatio's Objections (D.I. 89) are OVERRULED, Tolmar's Objections (D.I. 88) are OVERRULED (to the extent they are not moot), Judge Burke's Report (D.I. 77) is ADOPTED, and Tolmar's motion to dismiss (D.I. 12) is GRANTED-IN-PART and DENIED-IN-PART, all for the following reasons:

         1. The patent marking statute, 35 U.S.C. § 287(a), provides in relevant part that when a patentee or patent licensee makes or sells a product practicing the patent, the patentee can only recover damages from one who infringes the patent if: (1) the patentee or licensee has marked its product in the manner specified in Section 287(a) (i.e., the infringer has "constructive notice" of infringement); or (2) the patentee actually notifies the infringer of its infringement. In the case of actual notice, a patentee may only recover damages for infringement occurring after notice was given.

         2. The Report concludes that Section 287(a) bars Horatio from recovering damages for the '547 and '261 patents because: (1) a former owner of the patents-in-suit, ALZA Corporation ("ALZA"), marketed a product practicing the '547 and '261 patents; but (2) ALZA failed to mark its product in compliance with Section 287(a); (3) Horatio only first provided Tolmar with actual notice of infringement upon the filing of its Complaint in this case; and (4) the '547 and '261 patents expired before the Complaint was filed, so Tolmar cannot be liable for damages that would otherwise have accrued after receiving actual notice of infringement (due to the expiration of the patents). (Report at 7-20)

         3. Horatio contends that the Report errs in applying the word "patentee" in Section 287(a) to entities like Horatio - namely, "later-in-time assignees who never sold any product and never had a relationship with the entity that did sell product." (Horatio's Objs. at 6) To Horatio, 35 U.S.C. § 100(d), which defines "patentee," when read together with Section 287, "informs a statutory construction that applies, in the case of a successor in title, only to a successor in title that engages in 'making, offering for sale, or selling within the United States any patented article for or under them, or importing any patented article into the United States.'" (Id. at 5) (quoting 35 U.S.C. § 287(a)) As Horatio is none of these, it contends it is not subject to the requirements of Section 287(a). (Id.)

         4. The Court disagrees. As noted by the Report, Section 100(d) explicitly defines "patentee" to "include[] not only the patentee to whom the patent was issued but also the successors in title to the patentee." (Report at 16) (quoting 35 U.S.C. § 100(d)) Therefore, Horatio, as successor in interest to ALZA, is a "patentee" for purposes of Section 287(a), and is subject to the same requirements under Section 287(a) as its predecessors-in-title would be. (Id.)

         5. Horatio's argument that it is not subject to the marking requirement because it is not "in privity" with any entity that practiced the patents also lacks merit. (See Horatio's Objs. at 5-6) Horatio's contentions cannot overcome the text of Sections 100(d) and 287(a), noted above. (See also Report at 14-18) Additionally, while Horatio distinguishes cases based on the purported lack of privity here, it does not cite any authority actually supporting the proposition that the sale of a patent to an unrelated non-practicing entity absolves prior non-compliance with the marking requirement.

         6. Horatio further faults the Report for its treatment of Horatio's argument that "Section 287(a) should not limit its pre-suit damages . . . [because] there was no product continuity between the ALZA product that was allegedly unmarked and any product that Plaintiff has made or sold." (Horatio's Objs. at 6) (internal quotation marks and alterations omitted) This contention lacks merit. It appears that Horatio's "product continuity" argument is simply a restatement of its lack of privity argument already addressed, and so fails for the same reasons. To the extent this is, instead, an argument for a separate exception to Section 287(a) (i.e., where there is no product continuity), the Court agrees with the Report that this position was not fairly raised in Horatio's briefing (see D.I. 19 at 14-19) and, therefore, is waived.[3] (See Report at 15 n.4)

         7. Horatio argues that the Report errs in concluding that the listing of a product in the Orange Book as practicing specific patent(s) provides neither constructive nor actual notice of infringement under Section 287(a). (Horatio's Objs. at 8) For the reasons thoroughly stated in the Report, the ...


Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.